- Home
- COEP vs WVVI Comparison
COEP vs WVVI Comparison
Compare COEP & WVVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COEP
- WVVI
- Stock Information
- Founded
- COEP 2017
- WVVI 1983
- Country
- COEP United States
- WVVI United States
- Employees
- COEP N/A
- WVVI N/A
- Industry
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- WVVI Beverages (Production/Distribution)
- Sector
- COEP Health Care
- WVVI Consumer Staples
- Exchange
- COEP Nasdaq
- WVVI Nasdaq
- Market Cap
- COEP 32.0M
- WVVI 29.5M
- IPO Year
- COEP N/A
- WVVI N/A
- Fundamental
- Price
- COEP $9.15
- WVVI $5.87
- Analyst Decision
- COEP
- WVVI
- Analyst Count
- COEP 0
- WVVI 0
- Target Price
- COEP N/A
- WVVI N/A
- AVG Volume (30 Days)
- COEP 31.8K
- WVVI 4.8K
- Earning Date
- COEP 05-14-2025
- WVVI 05-13-2025
- Dividend Yield
- COEP N/A
- WVVI N/A
- EPS Growth
- COEP N/A
- WVVI N/A
- EPS
- COEP N/A
- WVVI N/A
- Revenue
- COEP $62,874.00
- WVVI $38,520,945.00
- Revenue This Year
- COEP N/A
- WVVI N/A
- Revenue Next Year
- COEP N/A
- WVVI N/A
- P/E Ratio
- COEP N/A
- WVVI N/A
- Revenue Growth
- COEP N/A
- WVVI N/A
- 52 Week Low
- COEP $2.31
- WVVI $3.17
- 52 Week High
- COEP $13.70
- WVVI $6.33
- Technical
- Relative Strength Index (RSI)
- COEP 46.80
- WVVI 48.22
- Support Level
- COEP $8.95
- WVVI $5.80
- Resistance Level
- COEP $9.85
- WVVI $5.96
- Average True Range (ATR)
- COEP 0.64
- WVVI 0.16
- MACD
- COEP -0.02
- WVVI 0.01
- Stochastic Oscillator
- COEP 10.47
- WVVI 41.97
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
About WVVI Willamette Valley Vineyards Inc.
Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.